{"id":"36c02df38dfc","type":"article","url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","title":"EAS-consensus: wereldwijde harmonisatie van lipidenklinieken","title_en":"Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics","category":"cholesterol","category_label":"Cholesterol","professions":["cardioloog","huisarts","internist"],"tags":["dyslipidemie","ezetimibe","familiaire-hypercholesterolemie-screening","lipidenverlaging","niet-statine-therapie","plaquekarakterisatie","statines"],"journal":"Atherosclerosis","doi":"https://www.atherosclerosis-journal.com/article/S0021-9150(26)00123-1/fulltext","source_url":"https://doi.org/https://www.atherosclerosis-journal.com/article/S0021-9150(26)00123-1/fulltext","authors":["Christian Bork","Børge G. Nordestgaard","Berit Storgaard Hedegaard","Michal Vrablik","Elsie Evans","Tomas Freiberger","Zlatko Fras","David Nanchen","Fouzia Sadiq","Kausik K. Ray","Kirsten Holven","Jeanine E. Roeters van Lennep","Ulrich Laufs","Marianne Benn","Shoaib Afzal","Evangelos Liberopoulos","Katariina Öörni","Meral Kayikcioglu","Mutaz Al-Khnifsawi","Khalid Al-Rasadi","Lambert Tetteh Appiah","Makhabbat Bekbossynova","Marianne Becker","Christoph J. Binder","Máxima Méndez Castillo","Mariia Cherska","Krzysztof Chlebus","Pablo Corral","Ronen Durst","Marat Ezhov","Dan Gaita","Federica Galimberti","Daniel Gaudet","Tea Gamezardashvili","Angel Alberto García-Peña","Urh Groselj","Mariko Harada-Shiba","Sergio Emanuel Kaiser","Gustavs Latkovskis","Vincent Maher","Winfried März","Lluís Masana","Anne Thushara Matthias","Ann Mertens","Olena Mitchenko","Adam J. Nelson","Stephen J. Nicholls","Richard C. O'Brien","Belma Pojskic","György Paragh","Zaneta Petrulioniene","Arman Postadzhiyan","Frederick J. Raal","Ashraf Reda","Ximena Reyes","Željko Reiner","Stefano Romeo","Carlos A. Aguilar Salinas","Erik S. Stroes","Phivos Symeonides","Aleksandr B. Shek","Alberto Mello e Silva","Tigist Mekonnen","Myra Tilney","Lale Tokgozoglu","Alexandros D. Tselepis","Margus Viigimaa","Branislav Vohnout","Luz Clemencia Zarate-Correa","Philippe Moulin","Writing group","EAS Lipid Clinic Network Committee","EAS Executive Committee","Other national leads for the EAS Lipid Clinic Network"],"significance":8,"published":"2026-06-04","source_date":"2026-05-24","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/familiaire-hypercholesterolemie/","https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/"],"congress":"","summary_en":"Through its Lipid Clinic Network, the European Atherosclerosis Society (EAS) presents the first worldwide consensus on lipid clinics, drawing on data from 55 countries and more than 500 clinics. Lipid clinics deliver specialised diagnostics, lifestyle management and evidence-based lipid-lowering therapy to high-risk patients — including those with familial hypercholesterolaemia, markedly elevated lipoprotein(a), statin intolerance, refractory LDL cholesterol, severe hypertriglyceridaemia and other rare or complex lipid disorders — to prevent atherosclerotic cardiovascular disease and acute pancreatitis. The statement defines lipid clinics across four tiers and offers practical guidance on staffing, referral criteria, Lp(a) and genetic testing, quality monitoring and funding, highlighting the major differences between countries by income level. The authors — including Jeanine Roeters van Lennep (Erasmus MC) — call for national and international harmonisation so that patients everywhere receive equitable, high-quality lipid care.","created":"2026-07-03T10:32:29Z","updated":"2026-07-03T13:31:26Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"De European Atherosclerosis Society (EAS) presenteert via haar Lipid Clinic Network de eerste wereldwijde consensus over lipidenklinieken, gebaseerd op gegevens uit 55 landen en meer dan 500 klinieken. Lipidenklinieken bieden gespecialiseerde diagnostiek, leefstijlbegeleiding en evidence-based lipidenverlagende behandeling aan hoogrisicopatiënten — onder wie mensen met familiaire hypercholesterolemie, sterk verhoogd lipoproteïne(a), statine-intolerantie, therapieresistent LDL-cholesterol, ernstige hypertriglyceridemie en andere zeldzame of complexe lipidenstoornissen — ter preventie van atherosclerotische hart- en vaatziekten en acute pancreatitis. Het statement definieert lipidenklinieken in vier niveaus en geeft praktische handvatten voor bemensing, verwijscriteria, Lp(a)- en genetische diagnostiek, kwaliteitsbewaking en financiering, met nadruk op de grote verschillen tussen landen naar inkomensniveau. De auteurs — onder wie Jeanine Roeters van Lennep (Erasmus MC) — roepen op tot nationale en internationale harmonisatie, zodat patiënten overal gelijkwaardige, hoogwaardige lipidenzorg krijgen.","abstract_original":"Because one in three of all individuals die from atherosclerotic cardiovascular disease (ASCVD), prevention of ASCVD is key to public health worldwide. Lipid clinics provide specialized diagnostic assessment, lifestyle management, and evidence-based lipid-lowering treatment to prevent ASCVD and acute pancreatitis in high-risk individuals. This includes individuals with familial hypercholesterolemia and/or markedly increased lipoprotein(a), statin intolerance, refractory or difficult-to-control low-density lipoprotein (LDL) cholesterol, severe hypertriglyceridaemia, and other rare or complex lipid disorders."}